참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Potassium Iodide | HCID 4875 | — |
| 반응물 | Morpholine | HCID 8083 | — |
| 반응물 | 2-(Chloromethyl)-5-(4-iodophenyl)-1,3,4-oxadiazole | HCID 7091068 | — |
| 생성물 | 4-[5-(4-Iodophenyl)-[1,3,4]oxadiazol-2-ylmethyl]-morpholine | HCID 69317784 | — |
반응 단계
2-Chloromethyl-5-(4-iodophenyl)-[1,3,4]oxadiazole (Intermediate 7) (48 mg, 0.15 mmol) and potassium iodide (25 mg, 0.15 mmol) were dissolved in morpholine (2 ml) and stirred for 18 hours at 20° C. The amine was then removed in vacuo and the product was purified on a 10 g silica SPE cartridge (stepped solvent gradient 80:20 ethyl acetate:cyclohexane, 100% ethyl acetate, 95:5 ethyl acetate:methanol).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07425555B2 |
|---|
| 출처 데이터셋 | uspto-grants-2008_09 |
|---|
| ORD ID | ord-5805fae0e74b44f8ba683b56cf40df60 |
|---|
| 출처 메모 | uspto-grants-2008_09 |
|---|
